text.skipToContent text.skipToNavigation
You searched for "T cells"
Too many choices? Use the filter option on the left to narrow your product listing.
41-50 of 1032 results
    TheraPEAK<sup class=reg>®</sup> P3 Primary Cell Nucleofector<sup class=reg>®</sup>  Solution Set (22.5 mL + 5 mL)
    Compare
    TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (22.5 mL + 5 mL)
    Catalog #: G4LP3-22500

    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.

    ST
    TheraPEAK<sup class=reg>®</sup> P3 Primary Cell Nucleofector<sup class=reg>®</sup> Solution Set (126 mL + 28 mL)
    Compare
    TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (126 mL + 28 mL)
    Catalog #: G4LP3-126000

    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.

    ST
    P3 Primary Cell 384-well Nucleofector<sup class=reg>®</sup> Kit
    Compare
    P3 Primary Cell 384-well Nucleofector® Kit
    Catalog #: V5SP-3002
    For high-throughput transfection of primary cells, e.g. human T cells, DCs or CD34, when working with the 384-well Nucleofector® System.
    SA
    P3 Primary Cell 384-well Nucleofector<sup class=reg>®</sup> Kit
    Compare
    P3 Primary Cell 384-well Nucleofector® Kit
    Catalog #: V5SP-3010
    For high-throughput transfection of primary cells, e.g. human T cells, DCs or CD34, when working with the 384-well Nucleofector® System.
    ST
    P3 Primary Cell 96-well Nucleofector<sup class=reg>®</sup> Kit
    Compare
    P3 Primary Cell 96-well Nucleofector® Kit
    Catalog #: V4SP-3096
    For medium-throughput transfection of primary cells, e.g. human T cells, CD34 or rat neurons, when working with the 4D-Nucleofector® 96-well Unit.
    SA
    P3 Primary Cell 96-well Nucleofector<sup class=reg>®</sup> Kit (960 RCT)
    Compare
    P3 Primary Cell 96-well Nucleofector® Kit (960 RCT)
    Catalog #: V4SP-3960
    For medium-throughput transfection of primary cells, e.g. human T cells, CD34+ or rat neurons, when working with the 4D-Nucleofector® 96-well Unit.
    SA
    RPTEC - Human Renal Proximal Tubule Epithelial Cells
    Compare
    RPTEC - Human Renal Proximal Tubule Epithelial Cells
    Catalog #: CC-2553
    Cryopreserved ampule of Human Renal Proximal Tubule Epithelial Cells (RPTEC) containing ≥ 500,000 cells
    EA
    AmpliCell<sup class=reg>®</sup> Recombinant Cytokines – IL-2, 10 µg
    Compare
    AmpliCell® Recombinant Cytokines – IL-2, 10 µg
    Catalog #: AC-HU02-10RUO

    AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.

    EA
    AmpliCell<sup class=reg>®</sup> Recombinant Cytokines – IL-2, 100 µg
    Compare
    AmpliCell® Recombinant Cytokines – IL-2, 100 µg
    Catalog #: AC-HU02-100RUO

    AmpliCell® recombinant cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.

    EA
    TheraPEAK<sup class=reg>®</sup> AmpliCell<sup class=reg>®</sup> Recombinant Cytokines – IL‑2, 10 µg
    Compare
    TheraPEAK® AmpliCell® Recombinant Cytokines – IL‑2, 10 µg
    Catalog #: AC-HU02-10GMP

    AmpliCell® Recombinant Cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.

    EA
1-10 of 1475 results
  • Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell Generation
    Poster on inducible Cas9 T Cells
  • Synthego_Lonza_Protocol_Genome Editing of Resting T cells
    Technical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
  • Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T Cells
    Instructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
  • PBMC Based T Cell Proliferation Assay
    Protocol instructions
  • Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCs
    Protocol for DC and T Cell Assay from Matched PBMCs
  • Case Study – Improving the Expansion of Patients' T Cells
    In this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
  • Large-scale editing of human T cells
    Watch Video
  • Synthego-Lonza Genome Editing of Resting T cells
    Case Study on Genome Editing of Resting T cells
  • A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell Expansion
    This poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.